Correlation Between Cytokinetics and Avidity Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cytokinetics and Avidity Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cytokinetics and Avidity Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cytokinetics and Avidity Biosciences, you can compare the effects of market volatilities on Cytokinetics and Avidity Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cytokinetics with a short position of Avidity Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cytokinetics and Avidity Biosciences.

Diversification Opportunities for Cytokinetics and Avidity Biosciences

0.23
  Correlation Coefficient

Modest diversification

The 3 months correlation between Cytokinetics and Avidity is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Cytokinetics and Avidity Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avidity Biosciences and Cytokinetics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cytokinetics are associated (or correlated) with Avidity Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avidity Biosciences has no effect on the direction of Cytokinetics i.e., Cytokinetics and Avidity Biosciences go up and down completely randomly.

Pair Corralation between Cytokinetics and Avidity Biosciences

Given the investment horizon of 90 days Cytokinetics is expected to generate 0.61 times more return on investment than Avidity Biosciences. However, Cytokinetics is 1.65 times less risky than Avidity Biosciences. It trades about 0.01 of its potential returns per unit of risk. Avidity Biosciences is currently generating about -0.01 per unit of risk. If you would invest  5,226  in Cytokinetics on August 29, 2024 and sell it today you would lose (24.00) from holding Cytokinetics or give up 0.46% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Cytokinetics  vs.  Avidity Biosciences

 Performance 
       Timeline  
Cytokinetics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cytokinetics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.
Avidity Biosciences 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Avidity Biosciences are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, Avidity Biosciences may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Cytokinetics and Avidity Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cytokinetics and Avidity Biosciences

The main advantage of trading using opposite Cytokinetics and Avidity Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cytokinetics position performs unexpectedly, Avidity Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avidity Biosciences will offset losses from the drop in Avidity Biosciences' long position.
The idea behind Cytokinetics and Avidity Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
FinTech Suite
Use AI to screen and filter profitable investment opportunities